Inventor · disambiguated record
Sourav Ghorai
Also filed as: GHORAI SOURAV
2 granted patents·8 pending applications·0 citations·filing 2022–2025
28Inventor score
Top patents by PatentIndex Score
10 records- 0171US12384753B217-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2022·Granted Aug 12, 2025·0 cites·6 claims
- 0270US2025376452A117-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use ThereofENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 0365US2025154163A1Pyrimidinone-Containing 17-Beta-Hydroxysteroid Dehydrogenase Type 13 InhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0462US11708348B2Protease inhibitors for treatment of coronavirus infectionsSCRIPPS RESEARCH INST·Filed 2022·Granted Jul 25, 2023·0 cites·4 claims
- 0561US2023416268A1Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitorsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 0661US2024325409A1Fused Heterotetracyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0760US2024368096A1Fused Heterobicyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0860US2024150318A1Protease inhibitors for treatment of coronavirus infectionsSCRIPPS RESEARCH INST·Filed 2023·Application pending·0 cites
- 0958US2024140922A1Fused heterobicyclic antiviral agentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 1046US2023033285A1Protease Inhibitors for Treatment of Coronavirus InfectionsSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →